The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests
- PMID: 15492914
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests
Abstract
Background/aims: Helicobacter pylori infection, is seen in more than 80% of adult population in Turkey. The aims of this study were 1) to evaluate the importance of the diagnostic tests 2) to investigate the relationship between Hp infection and functional dyspepsia.
Methods: A total 75 patients with functional-dyspepsia were involved into the study. Hp infection was diagnosed by histopathological examination. CLO, cytology, culture, stool antigen and breath test. Symptom score using ROME II criteria was also evaluated to all patients. All patients were taken ranitidine-bismuth-citrate (400mg bid/day), clarithromycin (500 mg bid/day) and amoxicillin (1000 mg bid/day) for 14 days. All tests and symptom score analyses were re-applied at month 1 and 6.
Results: The eradication rate was 95.9%. The baseline specifity of breath test, CLO, cytology, culture and stool antigen were 87.3%, 95.4%, 95.4% 94.5% and 86.4%, respectively. The sensitivity of such tests at first month after stopping the treatment were 86.1%, 100%, 100%, 100%, 84.7%, respectively, and were 91.6%, 100%, 100%, 100%, 87.5%, respectively at six months after treatment. Symptom scores were 29.6+/-5.4, 15.8+/-4.7 and 17.9+/-5.3 at baseline, first month and six months after treatment, respectively (p<0.001).
Conclusions: The success of eradication may be related to use of bismuth which prevents antibiotic resistance development. Stool antigen and breath tests are less effective than invasive diagnostic-tests. The finding of improved symptomscores after eradication suggests that Hp may play a role in functional dyspepsia.
Similar articles
-
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.Turk J Gastroenterol. 2005 Dec;16(4):203-6. Turk J Gastroenterol. 2005. PMID: 16547848
-
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.Z Gastroenterol. 2000 Mar;38(3):211-9. doi: 10.1055/s-2000-14860. Z Gastroenterol. 2000. PMID: 10768243 Clinical Trial.
-
Bismuth-based therapies for the first step eradication of Helicobacter pylori.Turk J Gastroenterol. 2006 Jun;17(2):90-3. Turk J Gastroenterol. 2006. PMID: 16830288 Clinical Trial.
-
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.Dig Liver Dis. 2015 Nov;47(11):903-12. doi: 10.1016/j.dld.2015.06.010. Epub 2015 Jul 6. Dig Liver Dis. 2015. PMID: 26253555
-
Role of Helicobacter pylori in functional dyspepsia.World J Gastroenterol. 2006 May 7;12(17):2677-80. doi: 10.3748/wjg.v12.i17.2677. World J Gastroenterol. 2006. PMID: 16718752 Free PMC article. Review.
Cited by
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment.Turk J Gastroenterol. 2025 Jun 16;36(7):467-473. doi: 10.5152/tjg.2025.24729. Turk J Gastroenterol. 2025. PMID: 40521801 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous